ImmunityBio
IBRX
#2599
Rank
NZ$11.70 B
Marketcap
NZ$11.00
Share price
-8.37%
Change (1 day)
187.55%
Change (1 year)

Earnings for ImmunityBio (IBRX)

Earnings in 2026 (TTM): -NZ$1.53 Billion

According to ImmunityBio's latest financial reports the company's current earnings are NZ$0.16 Billion. In 2025 the company made an earning of -NZ$0.44 Billion, an increase over its 2024 earnings that were of -NZ$0.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunityBio from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.53 Billion249.99%
2025 -NZ$0.44 Billion-16.85%
2024 -NZ$0.53 Billion-36.76%
2023 -NZ$0.84 Billion28.52%
2022 -NZ$0.65 Billion5.61%
2021 -NZ$0.62 Billion54.4%
2020 -NZ$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion-82.22%๐Ÿ‡บ๐Ÿ‡ธ USA